Webinar #1: Addressing Public Misperceptions About Palliative Care
Register for this event from the National Academies of Sciences, Engineering, and Medicine.
Register for this event from the National Academies of Sciences, Engineering, and Medicine.
On May 16, 2024, the FDA granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer.
During an OncLive Peer Exchange, a panel of expert clinicians in CRC discussed studies seeking to further define the role of MRD testing in CRC.
Stop asking the wrong question. Whether they smoked or never had a puff, all people with a lung cancer diagnosis deserve care and compassion.
USC’s Berislav Zlokovic has faced questions about the integrity of his research. Since a whistleblower report last year, several papers have been retracted and a…
Low-value care is defined “as the use of a health service for which the harms or costs outweigh the benefits”. In other words, if a…
We study the medium-run effect of Sure Start on academic outcomes, finding large benefits, particularly for children from disadvantaged backgrounds.
Prescription drug costs are a challenge for patients with cancer. The Mark Cuban Cost Plus Drug Company (MCCPDC) launched in 2022, aiming to provide transp
Chronic musculoskeletal pain remains a huge challenge for clinicians and researchers. Exercise interventions are the cornerstone of management for musculoskeletal pain conditions,1 with the benefits…
PURPOSE Targeted Agent and Profiling Utilization Registry is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with…
The vanity license plate program in Delaware is on pause after a judge’s ruling in a case involving a cancer survivor.